{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:27Z","timestamp":1790787807089,"version":"4.1.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bart's Charity"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/ W03011X\/1"],"award-info":[{"award-number":["MR\/ W03011X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recent clinical and research efforts in cardiogenic shock (CS) have largely focussed on the restoration of the low cardiac output state that is the\n                    <jats:italic>conditio sine qua non<\/jats:italic>\n                    of the clinical syndrome. This approach has failed to translate into improved outcomes, and mortality has remained static at 30\u201350%. There is an unmet need to better delineate the pathobiology of CS to understand the observed heterogeneity of presentation and treatment effect and to identify novel therapeutic targets. Despite data in other critical illness syndromes, specifically sepsis, the role of dysregulated inflammation and immunity is hitherto poorly described in CS. High-dimensional molecular profiling, particularly through leukocyte transcriptomics, may afford opportunity to better characterise subgroups of patients with shared mechanisms of immune dysregulation. In this state-of-the-art review, we outline the rationale for considering molecular subtypes of CS. We describe how high-dimensional molecular technologies can be used to identify these subtypes, and whether they share biological features with sepsis and other critical illness states. Finally, we propose how the identification of molecular subtypes of patients may enrich future clinical trial design and identification of novel therapies for CS.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s13054-023-04752-8","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T10:03:55Z","timestamp":1701079435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Extending the \u2018host response\u2019 paradigm from sepsis to cardiogenic shock: evidence, limitations and opportunities"],"prefix":"10.1186","volume":"27","author":[{"given":"Marie","family":"Buckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maclean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair G.","family":"Proudfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,27]]},"reference":[{"issue":"8","key":"4752_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/CCM.0000000000004948","volume":"49","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Berg DD, Park JG, Katz JN, Baird-Zars VM, Barsness GW, et al. The range of cardiogenic shock survival by clinical stage: data from the critical care cardiology trials network registry. Crit Care Med. 2021;49(8):1293\u2013302.","journal-title":"Crit Care Med"},{"key":"4752_CR2","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720\u2013826.","journal-title":"Eur Heart J"},{"key":"4752_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000525","author":"S van Diepen","year":"2017","unstructured":"van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary management of cardiogenic shock: a scientific statement from the american heart association. Circulation. 2017. https:\/\/doi.org\/10.1161\/CIR.0000000000000525.","journal-title":"Circulation"},{"issue":"8","key":"4752_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00392-015-0833-4","volume":"104","author":"C Jung","year":"2015","unstructured":"Jung C, Fuernau G, De Waha S, Eitel I, Desch S, Schuler G, et al. Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy. Clin Res Cardiol. 2015;104(8):679\u201387.","journal-title":"Clin Res Cardiol"},{"key":"4752_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejhf.857","volume":"19","author":"P Ostadal","year":"2017","unstructured":"Ostadal P, Rokyta R, Kruger A, Vondrakova D, Janotka M, Sm\u00edd O, et al. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial: extra corporeal membrane oxygenation in the therapy of cardiogenic Shock (ECMO-CS). Eur J Heart Fail. 2017;19:124\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4752_CR6","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jacc.2016.10.022","volume":"69","author":"DM Ouweneel","year":"2017","unstructured":"Ouweneel DM, Eriksen E, Sjauw KD, Van Dongen IM, Hirsch A, Packer EJS, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69(3):278\u201387.","journal-title":"J Am Coll Cardiol"},{"key":"4752_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1056\/NEJMoa2307227","volume":"389","author":"H Thiele","year":"2023","unstructured":"Thiele H, Zeymer U, Akin I, Behnes M, Rassaf T, Mahabadi AA, et al. Extracorporeal life support in infarct-related cardiogenic shock. N Engl J Med. 2023;389:1286\u201397.","journal-title":"N Engl J Med"},{"key":"4752_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S0140-6736(23)01607-0","volume":"402","author":"U Zeymer","year":"2023","unstructured":"Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R, et al. Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials. The Lancet. 2023;402:1338\u201346.","journal-title":"The Lancet"},{"issue":"9","key":"4752_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/S2213-2600(18)30287-X","volume":"6","author":"PR Lawler","year":"2018","unstructured":"Lawler PR, Fan E. Heterogeneity and phenotypic stratification in acute respiratory distress syndrome. Lancet Respir Med. 2018;6(9):651\u20133.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"4752_CR10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28(6):1141\u20138.","journal-title":"Nat Med"},{"issue":"14","key":"4752_CR11","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.020085","volume":"10","author":"E Zweck","year":"2021","unstructured":"Zweck E, Thayer KL, Helgestad OKL, Kanwar M, Ayouty M, Garan AR, et al. Phenotyping cardiogenic shock. JAHA. 2021;10(14): e020085.","journal-title":"JAHA"},{"key":"4752_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ccd.28329","volume":"94","author":"DA Baran","year":"2019","unstructured":"Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardiovasc Interv. 2019;94:29\u201337.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"4752_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s40119-022-00286-2","volume":"11","author":"HS Lim","year":"2022","unstructured":"Lim HS. Phenotyping and hemodynamic assessment in cardiogenic shock: from physiology to clinical application. Cardiol Ther. 2022;11(4):509\u201322.","journal-title":"Cardiol Ther"},{"issue":"1","key":"4752_CR14","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCRESAHA.121.318391","volume":"131","author":"A Toma","year":"2022","unstructured":"Toma A, Dos Santos C, Burzy\u0144ska B, G\u00f3ra M, Kiliszek M, Stickle N, et al. Diversity in the expressed genomic host response to myocardial infarction. Circ Res. 2022;131(1):106\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"4752_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","volume":"42","author":"PR Lawler","year":"2021","unstructured":"Lawler PR, Bhatt DL, Godoy LC, L\u00fcscher TF, Bonow RO, Verma S, et al. Targeting cardiovascular inflammation: next steps in clinical translation. Eur Heart J. 2021;42(1):113\u201331.","journal-title":"Eur Heart J"},{"issue":"7","key":"4752_CR16","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/ccd.29319","volume":"96","author":"DA Baran","year":"2020","unstructured":"Baran DA, Long A, Badiye AP, Stelling K. Prospective validation of the SCAI shock classification: single center analysis. Catheter Cardiovasc Interv. 2020;96(7):1339\u201347.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"4","key":"4752_CR17","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1002\/ccd.30103","volume":"99","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, Soussi S, Lawler PR, Kennedy JN, Kashani KB. Validation of cardiogenic shock phenotypes in a mixed cardiac intensive care unit population. Cathet Cardio Intervent. 2022;99(4):1006\u201314.","journal-title":"Cathet Cardio Intervent"},{"issue":"9","key":"4752_CR18","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2022.01.018","volume":"79","author":"SS Naidu","year":"2022","unstructured":"Naidu SS, Baran DA, Jentzer JC, Hollenberg SM, van Diepen S, Basir MB, et al. SCAI SHOCK stage classification expert consensus update: a review and incorporation of validation studies. J Am Coll Cardiol. 2022;79(9):933\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"4752_CR19","doi-asserted-by":"crossref","unstructured":"Zweck E, Kanwar M, Li S, Sinha SS, Garan AR, Hernandez-Montfort J, et al. Clinical course of patients in cardiogenic shock stratified by phenotype. JACC Heart Failure. 2023","DOI":"10.1016\/j.jchf.2023.05.007"},{"issue":"36","key":"4752_CR20","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726.","journal-title":"Eur Heart J"},{"key":"4752_CR21","doi-asserted-by":"publisher","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022. https:\/\/doi.org\/10.1161\/CIR.0000000000001063","DOI":"10.1161\/CIR.0000000000001063"},{"issue":"1","key":"4752_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40635-023-00531-5","volume":"11","author":"S Soussi","year":"2023","unstructured":"Soussi S, Dos Santos C, Jentzer JC, Mebazaa A, Gayat E, P\u00f6ss J, et al. Distinct host-response signatures in circulatory shock: a narrative review. ICMx. 2023;11(1):50.","journal-title":"ICMx"},{"issue":"9","key":"4752_CR23","doi-asserted-by":"publisher","first-page":"e007568","DOI":"10.1161\/CIRCHEARTFAILURE.120.007568","volume":"13","author":"JC Jentzer","year":"2020","unstructured":"Jentzer JC. Understanding cardiogenic shock severity and mortality risk assessment. Circ Heart Failure. 2020;13(9):e007568.","journal-title":"Circ Heart Failure."},{"issue":"3","key":"4752_CR24","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.chest.2021.09.032","volume":"161","author":"B Burstein","year":"2022","unstructured":"Burstein B, Van Diepen S, Wiley BM, Anavekar NS, Jentzer JC. Biventricular function and shock severity predict mortality in cardiac ICU patients. Chest. 2022;161(3):697\u2013709.","journal-title":"Chest"},{"issue":"9","key":"4752_CR25","doi-asserted-by":"publisher","first-page":"1007099","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","volume":"13","author":"KL Thayer","year":"2020","unstructured":"Thayer KL, Zweck E, Ayouty M, Garan AR, Hernandez-Montfort J, Mahr C, et al. Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock. Circ Heart Failure. 2020;13(9):1007099.","journal-title":"Circ Heart Failure."},{"issue":"4","key":"4752_CR26","doi-asserted-by":"publisher","first-page":"100120","DOI":"10.1016\/j.jacadv.2022.100120","volume":"1","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, Rayfield C, Soussi S, Berg DD, Kennedy JN, Sinha SS, et al. Advances in the staging and phenotyping of cardiogenic shock. JACC Adv. 2022;1(4):100120.","journal-title":"JACC Adv."},{"issue":"14","key":"4752_CR27","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","volume":"165","author":"S Kohsaka","year":"2005","unstructured":"Kohsaka S. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med. 2005;165(14):1643.","journal-title":"Arch Intern Med"},{"issue":"12","key":"4752_CR28","doi-asserted-by":"publisher","first-page":"1006956","DOI":"10.1161\/CIRCOUTCOMES.120.006956","volume":"13","author":"JC Jentzer","year":"2020","unstructured":"Jentzer JC, Lawler PR, Van Diepen S, Henry TD, Menon V, Baran DA, et al. Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes. 2020;13(12):1006956.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"10","key":"4752_CR29","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1164\/rccm.202204-0687OC","volume":"206","author":"H Merdji","year":"2022","unstructured":"Merdji H, Curtiaud A, Aheto A, Studer A, Harjola VP, Monnier A, et al. Performance of early capillary refill time measurement on outcomes in cardiogenic shock: an observational, prospective multicentric study. Am J Respir Crit Care Med. 2022;206(10):1230\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"4752_CR30","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1164\/rccm.202208-1523ED","volume":"206","author":"PR Lawler","year":"2022","unstructured":"Lawler PR, van Diepen S. Toward a broader characterization of macro- and microcirculatory uncoupling in cardiogenic shock. Am J Respir Crit Care Med. 2022;206(10):1192\u20133.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"4752_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12872-023-03185-z","volume":"23","author":"V Boyalla","year":"2023","unstructured":"Boyalla V, Gallego-Colon E, Spartalis M. Immunity and inflammation in cardiovascular disorders. BMC Cardiovasc Disord. 2023;23(1):148.","journal-title":"BMC Cardiovasc Disord"},{"key":"4752_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2016.00040\/full","author":"I Zlatanova","year":"2016","unstructured":"Zlatanova I, Pinto C, Silvestre JS. Immune modulation of cardiac repair and regeneration: the art of mending broken hearts. Front Cardiovasc Med. 2016. https:\/\/doi.org\/10.3389\/fcvm.2016.00040\/full.","journal-title":"Front Cardiovasc Med"},{"key":"4752_CR33","doi-asserted-by":"publisher","unstructured":"Gentek R, Hoeffel G. The innate immune response in myocardial infarction, repair, and regeneration. In: Sattler S, Kennedy-Lydon T, editors. The immunology of cardiovascular homeostasis and pathology. Cham: Springer International Publishing; 2017 [cited 2023 Jul 7]. p. 251\u201372. (Advances in Experimental Medicine and Biology; vol. 1003). https:\/\/doi.org\/10.1007\/978-3-319-57613-8_12","DOI":"10.1007\/978-3-319-57613-8_12"},{"issue":"9","key":"4752_CR34","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1097\/00003246-200209000-00007","volume":"30","author":"A Geppert","year":"2002","unstructured":"Geppert A, Steiner A, Zorn G, Delle-Karth G, Koreny M, Haumer M, et al. Multiple organ failure in patients with cardiogenic shock is associated with high plasma levels of interleukin-6. Crit Care Med. 2002;30(9):1987\u201394.","journal-title":"Crit Care Med"},{"key":"4752_CR35","unstructured":"Kataja A, Tarvasm\u00e4ki T, Lassus J, Sionis A, Mebazaa A, Pulkki K, et al. Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock\u2014Insights from the CardShock study. Int J Cardiol. 2020; https:\/\/www.internationaljournalofcardiology.com\/article\/S0167-5273(20)33652-4\/fulltext"},{"issue":"4","key":"4752_CR36","doi-asserted-by":"publisher","first-page":"R152","DOI":"10.1186\/cc11467","volume":"16","author":"RP Andri\u00e9","year":"2012","unstructured":"Andri\u00e9 RP, Becher UM, Frommold R, Tiyerili V, Schrickel JW, Nickenig G, et al. Interleukin-6 is the strongest predictor of 30-day mortality in patients with cardiogenic shock due to myocardial infarction. Crit Care. 2012;16(4):R152.","journal-title":"Crit Care"},{"issue":"8","key":"4752_CR37","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1007\/s00134-003-1827-7","volume":"29","author":"A Geppert","year":"2003","unstructured":"Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med. 2003;29(8):1384\u20139.","journal-title":"Intensive Care Med"},{"issue":"5","key":"4752_CR38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00392-007-0626-5","volume":"97","author":"M Debrunner","year":"2008","unstructured":"Debrunner M, Schuiki E, Minder E, Straumann E, Naegeli B, Mury R, et al. Proinflammatory cytokines in acute myocardial infarction with and without cardiogenic shock. Clin Res Cardiol. 2008;97(5):298\u2013305.","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"4752_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11739-009-0277-9","volume":"4","author":"C Picariello","year":"2009","unstructured":"Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S. Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med. 2009;4(5):403\u20138.","journal-title":"Intern Emerg Med"},{"issue":"5","key":"4752_CR40","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00392-011-0403-3","volume":"101","author":"R Prondzinsky","year":"2012","unstructured":"Prondzinsky R, Unverzagt S, Lemm H, Wegener NA, Schlitt A, Heinroth KM, et al. Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. Clin Res Cardiol. 2012;101(5):375\u201384.","journal-title":"Clin Res Cardiol"},{"issue":"6","key":"4752_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00063-012-0117-y","volume":"107","author":"R Prondzinsky","year":"2012","unstructured":"Prondzinsky R, Unverzagt S, Lemm H, Wegener N, Heinroth K, Buerke U, et al. Acute myocardial infarction and cardiogenic shock: Prognostic impact of cytokines: INF-\u03b3, TNF-\u03b1, MIP-1\u03b2, G-CSF, and MCP-1\u03b2. Med Klin Intensivmed Notfmed. 2012;107(6):476\u201384.","journal-title":"Med Klin Intensivmed Notfmed"},{"issue":"8","key":"4752_CR42","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/ejhf.117","volume":"16","author":"G Fuernau","year":"2014","unstructured":"Fuernau G, Poenisch C, Eitel I, De Waha S, Desch S, Schuler G, et al. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Eur J Heart Fail. 2014;16(8):880\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4752_CR43","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10238-014-0294-5","volume":"15","author":"J Lipkova","year":"2015","unstructured":"Lipkova J, Parenica J, Duris K, Helanova K, Tomandl J, Kubkova L, et al. Association of circulating levels of RANTES and \u2212403G\/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock. Clin Exp Med. 2015;15(3):405\u201314.","journal-title":"Clin Exp Med"},{"issue":"1","key":"4752_CR44","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12967-016-0869-x","volume":"14","author":"CH Liu","year":"2016","unstructured":"Liu CH, Kuo SW, Hsu LM, Huang SC, Wang CH, Tsai PR, et al. Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach. J Transl Med. 2016;14(1):114.","journal-title":"J Transl Med"},{"issue":"2","key":"4752_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/SHK.0000000000000756","volume":"47","author":"J Parenica","year":"2017","unstructured":"Parenica J, Jarkovsky J, Malaska J, Mebazaa A, Gottwaldova J, Helanova K, et al. Infectious complications and immune\/inflammatory response in cardiogenic shock patients: a prospective observational study. Shock. 2017;47(2):165\u201374.","journal-title":"Shock"},{"issue":"2","key":"4752_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ejhf.1600","volume":"22","author":"K Takagi","year":"2020","unstructured":"Takagi K, Blet A, Levy B, Deniau B, Azibani F, Feliot E, et al. Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial. Eur J Heart Fail. 2020;22(2):279\u201386.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"4752_CR47","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.1038\/s41598-020-64702-0","volume":"10","author":"J Cuinet","year":"2020","unstructured":"Cuinet J, Garbagnati A, Rusca M, Yerly P, Schneider AG, Kirsch M, et al. Cardiogenic shock elicits acute inflammation, delayed eosinophilia, and depletion of immune cells in most severe cases. Sci Rep. 2020;10(1):7639.","journal-title":"Sci Rep"},{"issue":"1","key":"4752_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/SHK.0000000000001342","volume":"53","author":"P B\u00fcttner","year":"2020","unstructured":"B\u00fcttner P, Obradovic D, Wunderlich S, Feistritzer HJ, Holzwirth E, Lauten P, et al. Selenoprotein P in myocardial infarction with cardiogenic shock. Shock. 2020;53(1):58\u201362.","journal-title":"Shock"},{"key":"4752_CR49","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jcrc.2021.12.005","volume":"68","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, Szekely Y, Burstein B, Ballal Y, Kim EY, van Diepen S, et al. Peripheral blood neutrophil-to-lymphocyte ratio is associated with mortality across the spectrum of cardiogenic shock severity. J Crit Care. 2022;68:50\u20138.","journal-title":"J Crit Care"},{"issue":"1","key":"4752_CR50","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41598-021-04519-7","volume":"12","author":"S Roth","year":"2022","unstructured":"Roth S, M\u2019Pembele R, Stroda A, Jansen C, Lurati Buse G, Boeken U, et al. Neutrophil-lymphoycyte-ratio, platelet-lymphocyte-ratio and procalcitonin for early assessment of prognosis in patients undergoing VA-ECMO. Sci Rep. 2022;12(1):542.","journal-title":"Sci Rep"},{"issue":"3","key":"4752_CR51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/jcm12030965","volume":"12","author":"J Dudda","year":"2023","unstructured":"Dudda J, Schupp T, Rusnak J, Weidner K, Abumayyaleh M, Ruka M, et al. C-reactive protein and white blood cell count in cardiogenic shock. JCM. 2023;12(3):965.","journal-title":"JCM"},{"issue":"38","key":"4752_CR52","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1093\/eurheartj\/ehad545","volume":"44","author":"FA Wenzl","year":"2023","unstructured":"Wenzl FA, Bruno F, Kraler S, Klingenberg R, Akhmedov A, Ministrini S, et al. Dipeptidyl peptidase 3 plasma levels predict cardiogenic shock and mortality in acute coronary syndromes. Eur Heart J. 2023;44(38):3859\u201371. https:\/\/doi.org\/10.1093\/eurheartj\/ehad545.","journal-title":"Eur Heart J"},{"issue":"6","key":"4752_CR53","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.amjcard.2006.10.040","volume":"99","author":"S Kohsaka","year":"2007","unstructured":"Kohsaka S, Menon V, Iwata K, Lowe A, Sleeper LA, Hochman JS. Microbiological profile of septic complication in patients with cardiogenic shock following acute myocardial infarction (from the SHOCK study). Am J Cardiol. 2007;99(6):802\u20134.","journal-title":"Am J Cardiol"},{"key":"4752_CR54","doi-asserted-by":"crossref","unstructured":"Nair RM, Kumar S, Saleem T, Chawla S, Vural A, Abdelghaffar B, et al. Characteristics and impact of bloodstream infections in cardiogenic shock patients on temporary mechanical circulatory support. JACC Cardiovasc Intervent. 2022; https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1936879822014029","DOI":"10.1016\/j.jcin.2022.07.017"},{"issue":"2","key":"4752_CR55","doi-asserted-by":"publisher","DOI":"10.1097\/CCE.0000000000000637","volume":"4","author":"JC Jentzer","year":"2022","unstructured":"Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR, et al. Concomitant sepsis diagnoses in acute myocardial infarction-cardiogenic shock: 15-year national temporal trends, management, and outcomes. Crit Care Explor. 2022;4(2): e0637.","journal-title":"Crit Care Explor"},{"issue":"12","key":"4752_CR56","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1093\/cid\/cis783","volume":"55","author":"M Schmidt","year":"2012","unstructured":"Schmidt M, Brechot N, Hariri S, Guiguet M, Luyt CE, Makri R, et al. Nosocomial infections in adult cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation. Clin Infect Dis. 2012;55(12):1633\u201341.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"4752_CR57","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1056\/NEJM198908033210503","volume":"321","author":"AF Suffredini","year":"1989","unstructured":"Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321(5):280\u20137.","journal-title":"N Engl J Med"},{"issue":"22","key":"4752_CR58","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1093\/eurheartj\/ehi389","volume":"26","author":"A Krack","year":"2005","unstructured":"Krack A, Sharma R, Figulla HR, Anker SD. The importance of the gastrointestinal system in the pathogenesis of heart failure. Eur Heart J. 2005;26(22):2368\u201374.","journal-title":"Eur Heart J"},{"issue":"6","key":"4752_CR59","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1016\/j.ijcard.2012.11.100","volume":"167","author":"P Attan\u00e0","year":"2013","unstructured":"Attan\u00e0 P, Lazzeri C, Chiostri M, Picariello C, Gensini GF, Valente S. Endotoxin role in cardiogenic shock: a brief report. Int J Cardiol. 2013;167(6):3031\u20132.","journal-title":"Int J Cardiol"},{"issue":"5","key":"4752_CR60","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/SHK.0000000000000798","volume":"47","author":"P Ramirez","year":"2017","unstructured":"Ramirez P, Villarreal E, Gordon M, G\u00f3mez MD, de Hevia L, Vacacela K, et al. Septic participation in cardiogenic shock: exposure to bacterial endotoxin. Shock. 2017;47(5):588\u201392.","journal-title":"Shock"},{"key":"4752_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.772413","volume":"8","author":"CT Lee","year":"2021","unstructured":"Lee CT, Wang CH, Chan WS, Tsai YY, Wei TJ, Lai CH, et al. Endotoxin activity in patients with extracorporeal membrane oxygenation life support: an observational pilot study. Front Med. 2021;8: 772413.","journal-title":"Front Med"},{"issue":"4","key":"4752_CR62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/CCM.0000000000005270","volume":"50","author":"F Venet","year":"2022","unstructured":"Venet F, Textoris J, Blein S, Rol ML, Bodinier M, Canard B, et al. Immune profiling demonstrates a common immune signature of delayed acquired immunodeficiency in patients with various etiologies of severe injury*. Crit Care Med. 2022;50(4):565\u201375.","journal-title":"Crit Care Med"},{"issue":"3","key":"4752_CR63","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1084\/jem.183.3.949","volume":"183","author":"A Kumar","year":"1996","unstructured":"Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med. 1996;183(3):949\u201358.","journal-title":"J Exp Med"},{"issue":"9404","key":"4752_CR64","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(03)15326-3","volume":"363","author":"N Pathan","year":"2004","unstructured":"Pathan N, Hemingway CA, Alizadeh AA, Stephens AC, Boldrick JC, Oragui EE, et al. Role of interleukin 6 in myocardial dysfunction of meningococcal septic shock. The Lancet. 2004;363(9404):203\u20139.","journal-title":"The Lancet"},{"issue":"12","key":"4752_CR65","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1097\/01.CCM.0000189943.60945.77","volume":"33","author":"RJ Levy","year":"2005","unstructured":"Levy RJ, Piel DA, Acton PD, Zhou R, Ferrari VA, Karp JS, et al. Evidence of myocardial hibernation in the septic heart*. Crit Care Med. 2005;33(12):2752\u20136.","journal-title":"Crit Care Med"},{"issue":"3","key":"4752_CR66","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/CCM.0000000000002207","volume":"45","author":"SJ Matkovich","year":"2017","unstructured":"Matkovich SJ, Al Khiami B, Efimov IR, Evans S, Vader J, Jain A, et al. Widespread down-regulation of cardiac mitochondrial and sarcomeric genes in patients with sepsis*. Crit Care Med. 2017;45(3):407\u201314.","journal-title":"Crit Care Med"},{"issue":"6","key":"4752_CR67","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","volume":"18","author":"SM Hollenberg","year":"2021","unstructured":"Hollenberg SM, Singer M. Pathophysiology of sepsis-induced cardiomyopathy. Nat Rev Cardiol. 2021;18(6):424\u201334.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"4752_CR68","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2174\/1389203718666170329104936","volume":"18","author":"A Sato","year":"2017","unstructured":"Sato A, Ogita H. Pathophysiological implications of dipeptidyl peptidases. CPPS. 2017;18(8):843\u20139.","journal-title":"CPPS."},{"issue":"1","key":"4752_CR69","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/BJ20061738","volume":"403","author":"R Wattiaux","year":"2007","unstructured":"Wattiaux R, Wattiaux-De Coninck S, Thirion J, Gasingirwa MC, Jadot M. Lysosomes and Fas-mediated liver cell death. Biochem J. 2007;403(1):89\u201395.","journal-title":"Biochem J"},{"issue":"6","key":"4752_CR70","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1373\/jalm.2018.027995","volume":"3","author":"L Rehfeld","year":"2019","unstructured":"Rehfeld L, Funk E, Jha S, Macheroux P, Melander O, Bergmann A. Novel methods for the quantification of dipeptidyl peptidase 3 (DPP3) concentration and activity in human blood samples. J Appl Lab Med. 2019;3(6):943\u201353.","journal-title":"J Appl Lab Med"},{"issue":"6","key":"4752_CR71","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/joim.13220","volume":"289","author":"D Lier","year":"2021","unstructured":"Lier D, Kox M, Pickkers P. Promotion of vascular integrity in sepsis through modulation of bioactive adrenomedullin and dipeptidyl peptidase 3. J Intern Med. 2021;289(6):792\u2013806.","journal-title":"J Intern Med"},{"issue":"32","key":"4752_CR72","doi-asserted-by":"publisher","first-page":"22316","DOI":"10.1074\/jbc.M803522200","volume":"283","author":"PK Baral","year":"2008","unstructured":"Baral PK, Jaj\u010danin-Jozi\u0107 N, Deller S, Macheroux P, Abrami\u0107 M, Gruber K. The first structure of dipeptidyl-peptidase III provides insight into the catalytic mechanism and mode of substrate binding. J Biol Chem. 2008;283(32):22316\u201324.","journal-title":"J Biol Chem"},{"issue":"2","key":"4752_CR73","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ejhf.1601","volume":"22","author":"B Deniau","year":"2020","unstructured":"Deniau B, Rehfeld L, Santos K, Dienelt A, Azibani F, Sadoune M, et al. Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics. Eur J Heart Fail. 2020;22(2):290\u20139.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"4752_CR74","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","volume":"72","author":"B Levy","year":"2018","unstructured":"Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2018;72(2):173\u201382.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4752_CR75","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/diagnostics13071350","volume":"13","author":"P Innelli","year":"2023","unstructured":"Innelli P, Lopizzo T, Patern\u00f2 G, Bruno N, Radice RP, Bertini P, et al. Dipeptidyl amino-peptidase 3 (DPP3) as an early marker of severity in a patient population with cardiogenic shock. Diagnostics. 2023;13(7):1350.","journal-title":"Diagnostics"},{"issue":"2","key":"4752_CR76","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.acvdsp.2023.03.065","volume":"15","author":"H Nordin","year":"2023","unstructured":"Nordin H, Picod A, Hartmann O, Santos K, Azibani F, Bergmann A, et al. Circulating DPP3 is an early predictor of mortality and organ support in patients with cardiogenic shock: post-hoc analyses of the ACCOST-HH trial. Arch Cardiovasc Diseases Suppl. 2023;15(2):208.","journal-title":"Arch Cardiovasc Diseases Suppl"},{"issue":"16","key":"4752_CR77","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.jacc.2022.08.740","volume":"80","author":"M B\u00f6hme","year":"2022","unstructured":"B\u00f6hme M, Desch S, Rosolowski M, Scholz M, Krohn K, B\u00fcttner P, et al. Impact of clonal hematopoiesis in patients with cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol. 2022;80(16):1545\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"4752_CR78","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1002\/ejhf.2588","volume":"24","author":"FL Scolari","year":"2022","unstructured":"Scolari FL, Abelson S, Brahmbhatt DH, Medeiros JJF, Fan CPS, Fung NL, et al. Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock. Eur J Heart Fail. 2022;24(9):1573\u201382.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"4752_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41569-019-0247-5","volume":"17","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S, Libby P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol. 2020;17(3):137\u201344.","journal-title":"Nat Rev Cardiol"},{"key":"4752_CR80","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.exphem.2020.01.011","volume":"83","author":"EK Cook","year":"2020","unstructured":"Cook EK, Luo M, Rauh MJ. Clonal hematopoiesis and inflammation: partners in leukemogenesis and comorbidity. Exp Hematol. 2020;83:85\u201394.","journal-title":"Exp Hematol"},{"issue":"25","key":"4752_CR81","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, et al. PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med. 2017;377(25):2419\u201332.","journal-title":"N Engl J Med"},{"issue":"10","key":"4752_CR82","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","volume":"139","author":"BM Everett","year":"2019","unstructured":"Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, et al. Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure. Circulation. 2019;139(10):1289\u201399.","journal-title":"Circulation"},{"issue":"8","key":"4752_CR83","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1161\/01.CIR.103.8.1044","volume":"103","author":"B Bozkurt","year":"2001","unstructured":"Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001;103(8):1044\u20137.","journal-title":"Circulation"},{"issue":"25","key":"4752_CR84","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-\u03b1, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation. 2003;107(25):3133\u201340.","journal-title":"Circulation"},{"issue":"8","key":"4752_CR85","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe DB, Burnham KL, Al-Beidh F, Santhakumaran S, Brett SJ, Hinds CJ, et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH randomized trial. Am J Respir Crit Care Med. 2019;199(8):980\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"4752_CR86","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","volume":"46","author":"TE Sweeney","year":"2018","unstructured":"Sweeney TE, Azad TD, Donato M, Haynes WA, Perumal TM, Henao R, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46(6):915.","journal-title":"Crit Care Med"},{"issue":"4","key":"4752_CR87","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","volume":"4","author":"EE Davenport","year":"2016","unstructured":"Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4(4):259\u201371.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"4752_CR88","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(17)30294-1","volume":"5","author":"BP Scicluna","year":"2017","unstructured":"Scicluna BP, van Vught LA, Zwinderman AH, Wiewel MA, Davenport EE, Burnham KL, et al. Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study. Lancet Respir Med. 2017;5(10):816\u201326.","journal-title":"Lancet Respir Med"},{"issue":"11","key":"4752_CR89","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-014-0111-5","volume":"6","author":"EL Tsalik","year":"2014","unstructured":"Tsalik EL, Langley RJ, Dinwiddie DL, Miller NA, Yoo B, van Velkinburgh JC, et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Med. 2014;6(11):111.","journal-title":"Genome Med"},{"key":"4752_CR90","doi-asserted-by":"publisher","first-page":"103776","DOI":"10.1016\/j.ebiom.2021.103776","volume":"75","author":"A Baghela","year":"2022","unstructured":"Baghela A, Pena OM, Lee AH, Baquir B, Falsafi R, An A, et al. Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures. EBioMedicine. 2022;75:103776.","journal-title":"EBioMedicine"},{"issue":"12","key":"4752_CR91","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1097\/CCM.0000000000005675","volume":"50","author":"C Fiorino","year":"2022","unstructured":"Fiorino C, Liu Y, Henao R, Ko ER, Burke TW, Ginsburg GS, et al. Host gene expression to predict sepsis progression. Crit Care Med. 2022;50(12):1748\u201356.","journal-title":"Crit Care Med"},{"issue":"669","key":"4752_CR92","doi-asserted-by":"publisher","first-page":"eabq4433","DOI":"10.1126\/scitranslmed.abq4433","volume":"14","author":"E Cano-Gamez","year":"2022","unstructured":"Cano-Gamez E, Burnham KL, Goh C, Allcock A, Malick ZH, Overend L, et al. An immune dysfunction score for stratification of patients with acute infection based on whole-blood gene expression. Sci Transl Med. 2022;14(669):eabq4433.","journal-title":"Sci Transl Med."},{"issue":"8","key":"4752_CR93","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.jacbts.2020.04.011","volume":"5","author":"KAS Silva","year":"2020","unstructured":"Silva KAS, Emter CA. Large animal models of heart\u00a0failure. JACC Basic Trans Sci. 2020;5(8):840\u201356.","journal-title":"JACC Basic Trans Sci"},{"issue":"Suppl 2","key":"4752_CR94","doi-asserted-by":"publisher","first-page":"P10","DOI":"10.1186\/cc3554","volume":"9","author":"C Tanamati","year":"2005","unstructured":"Tanamati C, Monachini M, Cantarelli M, Khouri P, Amarante G, Martins P, et al. Cardiogenic shock: an experimental animal model. Crit Care. 2005;9(Suppl 2):P10.","journal-title":"Crit Care"},{"issue":"12","key":"4752_CR95","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1093\/cvr\/cvab290","volume":"117","author":"Y Wang","year":"2021","unstructured":"Wang Y, Polten F, J\u00e4ckle F, Korf-Klingebiel M, Kempf T, Bauersachs J, et al. A mouse model of cardiogenic shock. Cardiovasc Res. 2021;117(12):2414\u20135.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"4752_CR96","doi-asserted-by":"publisher","first-page":"12417","DOI":"10.1038\/s41598-020-68571-5","volume":"10","author":"M Rienzo","year":"2020","unstructured":"Rienzo M, Imbault J, El Boustani Y, Beurton A, Carlos Sampedrano C, Pasdois P, et al. A total closed chest sheep model of cardiogenic shock by percutaneous intracoronary ethanol injection. Sci Rep. 2020;10(1):12417.","journal-title":"Sci Rep"},{"issue":"1","key":"4752_CR97","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s13054-019-2670-8","volume":"23","author":"D Braga","year":"2019","unstructured":"Braga D, Barcella M, Herpain A, Aletti F, Kistler EB, Bollen Pinto B, et al. A longitudinal study highlights shared aspects of the transcriptomic response to cardiogenic and septic shock. Crit Care. 2019;23(1):414.","journal-title":"Crit Care"},{"key":"4752_CR98","doi-asserted-by":"publisher","first-page":"1087721","DOI":"10.3389\/fcvm.2023.1087721","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Chen Y, Zhang T. Integrated whole-genome gene expression analysis reveals an atlas of dynamic immune landscapes after myocardial infarction. Front Cardiovasc Med. 2023;10:1087721.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"4752_CR99","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.cjca.2022.03.005","volume":"38","author":"BN Tehrani","year":"2022","unstructured":"Tehrani BN, Drakos SG, Billia F, Batchelor WB, Luk A, Stelling K, et al. The multicenter collaborative to enhance biologic understanding, quality, and outcomes in cardiogenic shock (VANQUISH Shock): rationale and design. Can J Cardiol. 2022;38(8):1286\u201395.","journal-title":"Can J Cardiol"},{"issue":"3","key":"4752_CR100","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14693","volume":"9","author":"NFL Heijnen","year":"2021","unstructured":"Heijnen NFL, Hagens LA, Smit MR, Schultz MJ, van der Poll T, Schnabel RM, et al. Biological subphenotypes of acute respiratory distress syndrome may not reflect differences in alveolar inflammation. Physiol Rep. 2021;9(3): e14693.","journal-title":"Physiol Rep"},{"issue":"1","key":"4752_CR101","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","volume":"9","author":"J Moss","year":"2018","unstructured":"Moss J, Magenheim J, Neiman D, Zemmour H, Loyfer N, Korach A, et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun. 2018;9(1):5068.","journal-title":"Nat Commun"},{"issue":"6","key":"4752_CR102","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/cc11508","volume":"16","author":"A Rhodes","year":"2012","unstructured":"Rhodes A, Cecconi M. Cell-free DNA and outcome in sepsis. Crit Care. 2012;16(6):170.","journal-title":"Crit Care"},{"issue":"1","key":"4752_CR103","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40635-019-0251-4","volume":"7","author":"NL Jackson Chornenki","year":"2019","unstructured":"Jackson Chornenki NL, Coke R, Kwong AC, Dwivedi DJ, Xu MK, McDonald E, et al. Comparison of the source and prognostic utility of cfDNA in trauma and sepsis. Intensive Care Med Exp. 2019;7(1):29.","journal-title":"Intensive Care Med Exp"},{"issue":"3","key":"4752_CR104","doi-asserted-by":"publisher","first-page":"R116","DOI":"10.1186\/cc13908","volume":"18","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Huici-Moreno MJ, Guti\u00e9rrez-Pizarraya A, L\u00f3pez I, M\u00e1rquez-V\u00e1caro JA, Macher H, et al. Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis. Crit Care. 2014;18(3):R116.","journal-title":"Crit Care"},{"issue":"6","key":"4752_CR105","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.cjca.2019.10.016","volume":"36","author":"T Yokokawa","year":"2020","unstructured":"Yokokawa T, Misaka T, Kimishima Y, Shimizu T, Kaneshiro T, Takeishi Y. Clinical significance of circulating cardiomyocyte-specific cell-free DNA in patients with heart failure: a proof-of-concept study. Can J Cardiol. 2020;36(6):931\u20135.","journal-title":"Can J Cardiol"},{"issue":"1","key":"4752_CR106","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1038\/s41467-018-03961-y","volume":"9","author":"H Zemmour","year":"2018","unstructured":"Zemmour H, Planer D, Magenheim J, Moss J, Neiman D, Gilon D, et al. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat Commun. 2018;9(1):1443.","journal-title":"Nat Commun"},{"issue":"4","key":"4752_CR107","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.medj.2023.03.006","volume":"4","author":"A Peretz","year":"2023","unstructured":"Peretz A, Loyfer N, Piyanzin S, Ochana BL, Neiman D, Magenheim J, et al. The DNA methylome of human vascular endothelium and its use in liquid biopsies. Med. 2023;4(4):263-281.e4.","journal-title":"Med"},{"issue":"5","key":"4752_CR108","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1378\/chest.124.5.1885","volume":"124","author":"N Lim","year":"2003","unstructured":"Lim N, Dubois MJ, De Backer D, Vincent JL. Do all nonsurvivors of cardiogenic shock die with a low cardiac index?*. Chest. 2003;124(5):1885\u201391.","journal-title":"Chest"},{"issue":"1","key":"4752_CR109","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12873-018-0171-8","volume":"18","author":"R El Sibai","year":"2018","unstructured":"El Sibai R, Bachir R, El Sayed M. ECMO use and mortality in adult patients with cardiogenic shock: a retrospective observational study in U.S. hospitals. BMC Emerg Med. 2018;18(1):20.","journal-title":"BMC Emerg Med"},{"issue":"13","key":"4752_CR110","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1084\/jem.20111354","volume":"208","author":"W Xiao","year":"2011","unstructured":"Xiao W, Mindrinos MN, Seok J, Cuschieri J, Cuenca AG, Gao H, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581\u201390.","journal-title":"J Exp Med"},{"issue":"2","key":"4752_CR111","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.1097\/SLA.0000000000003974","volume":"275","author":"LPA Neyton","year":"2022","unstructured":"Neyton LPA, Zheng X, Skouras C, Doeschl-Wilson A, Gutmann MU, Uings I, et al. Molecular patterns in acute pancreatitis reflect generalizable endotypes of the host response to systemic injury in humans. Ann Surg. 2022;275(2):e453\u201362.","journal-title":"Ann Surg"},{"issue":"1","key":"4752_CR112","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/01.CCM.0000251640.77679.D7","volume":"35","author":"SE Orfanos","year":"2007","unstructured":"Orfanos SE, Kotanidou A, Glynos C, Athanasiou C, Tsigkos S, Dimopoulou I, et al. Angiopoietin-2 is increased in severe sepsis: correlation with inflammatory mediators. Crit Care Med. 2007;35(1):199\u2013206.","journal-title":"Crit Care Med"},{"issue":"4","key":"4752_CR113","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/CCM.0b013e318206d285","volume":"39","author":"DR Ricciuto","year":"2011","unstructured":"Ricciuto DR, Dos Santos CC, Hawkes M, Toltl LJ, Conroy AL, Rajwans N, et al. Angiopoietin-1 and angiopoietin-2 as clinically informative prognostic biomarkers of morbidity and mortality in severe sepsis*. Crit Care Med. 2011;39(4):702\u201310.","journal-title":"Crit Care Med"},{"issue":"11","key":"4752_CR114","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1002\/ejhf.342","volume":"17","author":"J P\u00f6ss","year":"2015","unstructured":"P\u00f6ss J, Fuernau G, Denks D, Desch S, Eitel I, De Waha S, et al. Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the IABP-SHOCK II-Trial: angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock. Eur J Heart Fail. 2015;17(11):1152\u201360.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"4752_CR115","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/SHK.0000000000001123","volume":"50","author":"M Frydland","year":"2018","unstructured":"Frydland M, Ostrowski SR, M\u00f8ller JE, Hadziselimovic E, Holmvang L, Ravn HB, et al. Plasma concentration of biomarkers reflecting endothelial cell- and glycocalyx damage are increased in patients with suspected ST-elevation myocardial infarction complicated by cardiogenic shock. Shock. 2018;50(5):538\u201344.","journal-title":"Shock"},{"issue":"6","key":"4752_CR116","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","volume":"19","author":"A Zarbock","year":"2023","unstructured":"Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, et al. Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol. 2023;19(6):401\u201317.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4752_CR117","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13613-023-01130-z","volume":"13","author":"H Merdji","year":"2023","unstructured":"Merdji H, Levy B, Jung C, Ince C, Siegemund M, Meziani F. Microcirculatory dysfunction in cardiogenic shock. Ann Intensive Care. 2023;13(1):38.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"4752_CR118","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13613-016-0229-2","volume":"7","author":"H Tolppanen","year":"2017","unstructured":"Tolppanen H, Rivas-Lasarte M, Lassus J, Sans-Rosell\u00f3 J, Hartmann O, Lindholm M, et al. Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock. Ann Intensive Care. 2017;7(1):6.","journal-title":"Ann Intensive Care"},{"issue":"13","key":"4752_CR119","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1001\/jama.2023.3576","volume":"329","author":"IJ Dahabreh","year":"2023","unstructured":"Dahabreh IJ, Kazi DS. Toward personalizing care: assessing heterogeneity of treatment effects in randomized trials. JAMA. 2023;329(13):1063.","journal-title":"JAMA"},{"issue":"13","key":"4752_CR120","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1001\/jama.2023.3651","volume":"329","author":"EC Goligher","year":"2023","unstructured":"Goligher EC, Lawler PR, Jensen TP, Talisa V, Berry LR, Lorenzi E, et al. Heterogeneous treatment effects of therapeutic-dose heparin in patients hospitalized for COVID-19. JAMA. 2023;329(13):1066.","journal-title":"JAMA"},{"issue":"14","key":"4752_CR121","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.2023.4480","volume":"329","author":"S Florescu","year":"2023","unstructured":"Writing Committee for the REMAP-CAP Investigators, Florescu S, Stanciu D, Zaharia M, Kosa A, Codreanu D, et al. Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19: a randomized clinical trial. JAMA. 2023;329(14):1183.","journal-title":"JAMA"},{"key":"4752_CR122","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.coisb.2017.04.003","volume":"2","author":"CD Russell","year":"2017","unstructured":"Russell CD, Baillie JK. Treatable traits and therapeutic targets: Goals for systems biology in infectious disease. Curr Opin Syst Biol. 2017;2:140\u20136.","journal-title":"Curr Opin Syst Biol"},{"issue":"1","key":"4752_CR123","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","volume":"16","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol. 2020;16(1):20\u201331.","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"4752_CR124","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/anae.13870","volume":"72","author":"M Shankar-Hari","year":"2017","unstructured":"Shankar-Hari M, Rubenfeld GD. The use of enrichment to reduce statistically indeterminate or negative trials in critical care. Anaesthesia. 2017;72(5):560\u20135.","journal-title":"Anaesthesia"},{"issue":"5","key":"4752_CR125","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509\u201318.","journal-title":"JAMA"},{"issue":"1","key":"4752_CR126","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004709","volume":"49","author":"HR Wong","year":"2021","unstructured":"Wong HR, Hart KW, Lindsell CJ, Sweeney TE. External corroboration that corticosteroids may be harmful to septic shock endotype a patients. Crit Care Med. 2021;49(1): e98.","journal-title":"Crit Care Med"},{"issue":"14","key":"4752_CR127","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. Effect of targeted polymyxin B Hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320(14):1455.","journal-title":"JAMA"},{"issue":"12","key":"4752_CR128","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44(12):2205\u201312.","journal-title":"Intensive Care Med"},{"issue":"3","key":"4752_CR129","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066496","volume":"13","author":"J Fleuriet","year":"2023","unstructured":"Fleuriet J, Heming N, Meziani F, Reignier J, Declerq PL, Mercier E, et al. Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS): study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial. BMJ Open. 2023;13(3): e066496.","journal-title":"BMJ Open"},{"issue":"1","key":"4752_CR130","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13054-019-2446-1","volume":"23","author":"S Santhakumaran","year":"2019","unstructured":"Santhakumaran S, Gordon A, Prevost AT, O\u2019Kane C, McAuley DF, Shankar-Hari M. Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials. Crit Care. 2019;23(1):156.","journal-title":"Crit Care"},{"issue":"7472","key":"4752_CR131","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1136\/bmj.329.7472.966","volume":"329","author":"S Senn","year":"2004","unstructured":"Senn S. Individual response to treatment: is it a valid assumption? BMJ. 2004;329(7472):966\u20138.","journal-title":"BMJ"},{"issue":"7733","key":"4752_CR132","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/d41586-018-07535-2","volume":"563","author":"S Senn","year":"2018","unstructured":"Senn S. Statistical pitfalls of personalized medicine. Nature. 2018;563(7733):619\u201321.","journal-title":"Nature"},{"issue":"1","key":"4752_CR133","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/cpt.1372","volume":"106","author":"JS Gewandter","year":"2019","unstructured":"Gewandter JS, McDermott MP, He H, Gao S, Cai X, Farrar JT, et al. Demonstrating heterogeneity of treatment effects among patients: an overlooked but important step toward precision medicine. Clin Pharmacol Ther. 2019;106(1):204\u201310.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"4752_CR134","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1161\/CIRCULATIONAHA.121.058113","volume":"145","author":"PR Lawler","year":"2022","unstructured":"Lawler PR, Hochman JS, Zarychanski R. What are adaptive platform clinical trials and what role may they have in cardiovascular medicine? Circulation. 2022;145(9):629\u201332.","journal-title":"Circulation"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04752-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04752-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T10:11:50Z","timestamp":1701079910000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04752-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":134,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4752"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04752-8","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,27]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and materials"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"460"}}